Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ARBUTUS-BIOPHARMA-CORPORA-23319313/news/Arbutus-LNP-Licensee-Alnylam-Receives-Accelerated-Assessment-of-Patisiran-from-European-Medicines-25498930/?utm_source=whatsapp&utm_medium=social&utm_campaign=share